查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950523

帕金森氏症监测设备市场按产品类型、技术、最终用户和分销管道划分，全球预测（2026-2032年）

Parkinson's Disease Monitoring Device Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年帕金森氏症监测设备市场价值为 2.3747 亿美元，预计到 2026 年将成长至 2.6292 亿美元，到 2032 年将达到 4.4091 亿美元，复合年增长率为 9.24%。

关键市场统计数据
基准年 2025 2.3747亿美元
预计年份：2026年 2.6292亿美元
预测年份 2032 4.4091亿美元
复合年增长率 (%) 9.24%

随着临床医生、患者和技术提供者逐渐达成共识，帕金森氏症监测设备的发展日新月异，他们开始寻求远端、客观地测量运动和非运动症状。新型感测器技术、讯号处理技术的进步以及日益复杂的资料架构，使得持续的症状追踪成为可能，从而能够补充临床评估。这些功能正在重塑治疗路径，使早期疗育成为可能，优化药物剂量，并以高解析度的数位终点支持临床试验。

在此背景下，相关人员正努力应对动态的监管和报销环境，该环境要求产品具备可证实的临床疗效，并能与电子健康记录系统互通性。设备外形、病患接受度以及与临床工作流程的整合程度都会影响其应用。最终，市场将重点放在检验的疗效、以患者为中心的设计以及可扩展的数据管理上，从而为製造商、服务供应商和医疗保健系统创造机会，使其能够在疾病管理和研究效率方面实现可衡量的改进。

感测器技术、人工智慧和不断发展的临床实践的进步正在加速和重新定义帕金森氏症监测策略的采用。

近年来，技术的成熟和临床需求的转变共同推动了该领域的变革。感测器小型化和电池续航力的提升，使得外形规格从固定式扩展到可穿戴植入设备，从而能够在真实环境中持续采集步态、震颤和电生理讯号。同时，资料分析（尤其是机器学习和人工智慧）技术的进步，提高了从杂讯较大的纵向资料集中提取具有临床意义特征的准确性，从而实现了个性化的症状分析和预测分析，进而指南治疗方案的调整。

评估2025年美国关税调整对医疗设备生态系统供应链、采购和分销策略的策略性连锁反应。

影响跨境贸易的政策行动会透过改变零件成本、供应商选择和分销经济效益，对帕金森氏症监测设备生态系统产生重大影响。美国在2025年实施的关税调整迫使製造商和采购团队重新评估其关键零件的筹资策略，例如加速计、陀螺仪、肌电图感测器以及嵌入穿戴式装置和非穿戴式装置中的半导体元件。因此，设备设计人员越来越重视供应链的韧性和供应商多元化，以降低贸易相关成本波动所带来的风险。

产品类型、终端用户环境、分销管道和底层技术等方面的细緻细分将如何决定差异化的开发和商业化路径

基于细分市场的洞察揭示了不同产品类型、最终用户、分销管道和底层技术所呈现的独特发展和应用路径。非穿戴式装置和穿戴式装置之间的差异决定了设计重点和临床应用场景。非穿戴式设备，例如行动应用、固定係统和桌面设备，往往强调实验室层级的精确度和与临床工作流程的整合。而穿戴式解决方案，例如鞋类穿戴设备、植入式设备和腕戴式设备，则优先考虑持续的实际环境监测和患者舒适度。在植入式技术中，深部脑部刺激系统和神经刺激设备占据着一个高度复杂且监管严格的细分市场，需要进行外科手术和长期追踪。而腕戴式设备，分为健身手环和智慧型手錶，则兼顾了消费者友善的人体工学设计和临床级别的感测功能。

区域趋势和医疗保健体係差异正在导致全球市场采纳、监管要求和市场进入策略的差异。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的技术采纳、监管预期和报销方式，为医疗器材开发商带来不同的机会和挑战。在美洲，强大的临床研究基础设施和对价值医疗日益增长的关注推动了早期临床检验和私人支付方的参与，而北美製造和分销中心则影响着采购决策和市场进入时机。在欧洲、中东和非洲，区域​​监管协调框架和对临床证据的重视正在推动系统性的采纳曲线，该曲线评估那些展现出互通性和长期疗效的医疗器材。

硬体製造商、感测器供应商、分析技术先驱和临床研究合作伙伴之间的竞争与合作动态推动了产品差异化。

对主要企业的深入分析表明，成熟的医疗设备製造商、专业感测器供应商、数位医疗Start-Ups和专注于研究的测量设备製造商能够提供互补的能力。现有医疗设备公司倾向于利用其深厚的临床关係和监管经验，将植入式和临床级固定係统推向市场。同时，新参与企业和科技公司正在推动穿戴式装置和麵向消费者的介面（便于家庭监测）的开发。感测器製造商提供底层硬件，例如加速计、陀螺仪和肌电图 (EMG) 感测器，这些硬体的品质直接影响讯号保真度和分析性能，因此与供应商建立策略伙伴关係至关重要。

制定切实可行的策略重点和营运措施，以增强韧性、加速临床应用并创造差异化的价值提案

产业领导者可以采取一系列切实可行的措施来巩固市场地位、加速产品推广并降低营运风险。首先，优先考虑临床检验和互通性可以减少医院、神经科诊所和研究机构采用该产品的障碍。投资于同行评审的研究并加强与电子健康记录 (EHR) 的整合能力，可以提高可靠性和易用性。其次，透过双源采购、战略库存缓衝以及尽可能采用近岸外包来建立具有韧性的供应链，可以降低关税引起的成本波动和零件短缺的风险。这些措施有助于维持生产的连续性，并防止成本突然上涨。

透明且可复製的调查方法结合了深度访谈、技术评估和跨细分市场分析，以确保获得基于证据的见解。

本分析的调查方法结合了定性和定量证据收集，以确保研究结果的可靠性和可重复性。主要研究包括对临床医生、采购负责人、医疗设备工程师和临床试验申办者进行结构化访谈，以获取有关临床效用、易用性和采购因素的第一手资讯。此外，还对设备的外形尺寸和感测器规格进行了技术评估，为比较其在实际应用中的保真度和适用性提供了基础。次要研究则利用了监管指南、同行评审的临床文献和公开的技术文件来检验临床和技术方面的论点。

临床、技术和商业性需求的整合将决定帕金森氏症监测技术领域不断发展的格局中的最终赢家。

总之，帕金森氏症监测设备生态系统正处于一个转折点，技术能力、对长期客观数据的临床需求以及不断变化的商业性动态在此交汇融合。在此环境下取得成功，需要设备设计与终端使用者工作流程高度契合，拥有强有力的临床效用证据，并制定能够反映当地监管和报销实际情况的适应性商业策略。随着关税调整等政策措施对零件成本和生产决策产生影响，供应链韧性和策略采购决策的重要性日益凸显。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 帕金森氏症监测设备市场（依产品类型划分）

  • 非穿戴式装置
    • 行动应用
    • 静止系统
    • 桌面设备
  • 穿戴式装置
    • 鞋类穿戴装置
    • 植入式装置
      • 深部脑部刺激
      • 神经刺激设备
    • 腕戴式穿戴装置
      • 健身手环
      • 智慧型手錶

9. 按技术分類的帕金森氏症监测设备市场

  • 数据分析技术
    • 人工智慧演算法
    • 机器学习
  • 感测器技术
    • 加速计
    • 肌电感测器
    • 陀螺仪

第十章 帕金森氏症监测设备市场（依最终用户划分）

  • 居家照护环境
    • 辅助住宅
    • 病人家
  • 医院和诊所
    • 综合医院
    • 神经内科诊所
  • 研究所
    • 生技公司
    • 大学

第十一章 帕金森氏症监测设备市场（依通路划分）

  • 线下销售
    • 向医院销售
    • 专卖店
  • 线上销售
    • 直销
    • 第三方零售商

12. 各地区帕金森氏症监测设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 帕金森氏症监测设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国帕金森氏症监测设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国帕金森氏症监测设备市场

第十六章：中国帕金森氏症监测设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Biogen Inc.
  • BlueSky Medical Group
  • Boston Scientific Corporation
  • Byteflies NV
  • Clario
  • Cleveland Medical Devices Inc.
  • Gait Up SA
  • GE Healthcare, Inc.
  • Global Data Sciences Inc.
  • Great Lakes NeuroTechnologies, Inc.
  • Koneksa Health Corporation
  • Koninklijke Philips NV
  • MC10 Inc.
  • Medtronic plc
  • mHealth Technologies Srl
  • NeuroMetrix, Inc.
  • PKG Health Ltd.
  • Roche Holding AG
  • Siemens Healthineers AG
  • uMotif Limited
  • Verily Life Sciences LLC
Product Code: MRR-4F7A6D4FD8BA

The Parkinson's Disease Monitoring Device Market was valued at USD 237.47 million in 2025 and is projected to grow to USD 262.92 million in 2026, with a CAGR of 9.24%, reaching USD 440.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 237.47 million
Estimated Year [2026] USD 262.92 million
Forecast Year [2032] USD 440.91 million
CAGR (%) 9.24%

The evolution of Parkinson's disease monitoring devices has accelerated as clinicians, patients, and technology providers converge on remote, objective measurement of motor and non-motor symptoms. New sensor modalities, advances in signal processing, and increasingly sophisticated data architectures now enable continuous symptom tracking that complements clinical assessment. These capabilities are reshaping care pathways by enabling earlier intervention, improving medication titration, and supporting clinical trials with high-resolution digital endpoints.

Against this backdrop, stakeholders are navigating a dynamic regulatory and reimbursement environment that demands demonstrable clinical validity and interoperability with electronic health records. Adoption is influenced by device form factors, patient acceptance, and integration into clinical workflows. The cumulative effect is a market that prioritizes validated outcomes, patient-centric design, and scalable data management-creating opportunities for manufacturers, service providers, and healthcare systems to deliver measurable improvements in disease management and research efficiency.

How sensor advances, artificial intelligence, and clinical practice evolution are jointly accelerating adoption and redefining monitoring strategies for Parkinson's disease

Recent years have witnessed transformative shifts in the landscape driven by converging technological maturity and shifting clinical priorities. Sensor miniaturization and improvements in battery life have broadened viable form factors from stationary systems to wearable and implantable devices, allowing continuous capture of gait, tremor, and electrophysiological signals in real-world contexts. Parallel progress in data analysis-especially machine learning and AI-has improved the extraction of clinically meaningful features from noisy, longitudinal datasets, enabling personalized symptom profiling and predictive analytics that inform therapy adjustments.

Clinically, there has been a transition from episodic, clinic-based assessments toward longitudinal monitoring that reflects day-to-day variability. This shift elevates the role of home-based monitoring in therapeutic decision-making and in decentralized clinical trials. Health systems and payers are increasingly focused on outcomes and value, which pressures vendors to demonstrate clinical utility and cost-effectiveness. Moreover, interoperability expectations have risen; devices must integrate securely with care platforms and electronic health records while meeting privacy and regulatory requirements. In response, partnerships across medical device companies, technology providers, and clinical institutions have become strategic imperatives, accelerating product maturation and adoption pathways.

Assessing the strategic ripple effects of United States tariff changes in 2025 on supply chains, sourcing choices, and distribution strategies across the device ecosystem

Policy measures affecting cross-border trade can materially influence the Parkinson's disease monitoring device ecosystem by altering component costs, supplier selection, and distribution economics. Changes to tariffs implemented in the United States in 2025 have generated a need for manufacturers and procurement teams to reassess sourcing strategies for critical components such as accelerometers, gyroscopes, EMG sensors, and semiconductor elements embedded in wearable and non-wearable devices. As a result, device designers are placing elevated emphasis on supply chain resilience and supplier diversification to mitigate exposure to trade-related cost volatility.

In addition, tariffs have implications for the competitive landscape. Domestic assembly or nearshoring becomes a more attractive proposition for companies seeking to avoid import duties, which may accelerate investments in regional manufacturing capacity. Distribution channels also adapt; hospital buyers and specialty retailers evaluate total landed cost and lead times, while online direct sales models can provide alternative routes to market that reduce intermediary costs. For research institutes and biotech firms reliant on imported instrumentation, procurement timelines and depreciation assumptions are being revisited. Collectively, these dynamics contribute to strategic shifts in procurement, production footprint decisions, and partnership models across the ecosystem, underscoring the need for agile commercial and operational responses.

How nuanced segmentation across product types, end-user settings, distribution channels, and enabling technologies determines differentiated development and commercialization pathways

Segmentation-driven insight reveals distinct development and adoption pathways across product types, end users, distribution channels, and enabling technologies. Product type distinctions between non-wearable and wearable devices shape design priorities and clinical use cases: non-wearable categories such as mobile apps, stationary systems, and tabletop devices often emphasize laboratory-grade fidelity and integration into clinical workflows, whereas wearable solutions including footwear wearables, implantable devices, and wrist-worn wearables prioritize continuous, real-world monitoring and patient comfort. Within implantable technologies, deep brain stimulation systems and neurostimulators occupy a high-complexity, high-regulation niche requiring surgical pathways and long-term follow-up, while wrist-worn wearables split into fitness bands and smart watches that balance consumer ergonomics with clinical-grade sensing.

End-user segmentation likewise dictates deployment models and product requirements. Home care settings, which encompass assisted living facilities and patient homes, demand ease of use, remote management capabilities, and battery longevity. Hospitals and clinics, ranging from general hospitals to neurology clinics, prioritize integration into electronic health records, clinical validation, and workflow compatibility. Research institutes, including biotech firms and universities, require flexible, high-resolution data capture and interoperability with analytic pipelines for trial endpoints. Distribution channel nuances influence commercialization pathways; offline sales through hospital procurement and specialty stores typically involve clinical evaluation cycles and institutional contracting, while online channels-via direct sales and third-party retailers-favor scalable marketing, streamlined logistics, and faster patient access. Finally, technology segmentation highlights the centrality of data analysis and sensor technology: data analysis technologies such as AI algorithms and machine learning are critical to converting raw signals into actionable clinical insights, while sensor components like accelerometers, EMG sensors, and gyroscopes determine the fidelity and types of signals available for analysis. Taken together, these segmentation lenses inform prioritized investment, regulatory strategies, and go-to-market approaches tailored to device form factor, care setting, and user needs.

Regional dynamics and healthcare system variations that shape differential adoption, regulatory requirements, and go-to-market strategies across global markets

Regional dynamics affect technology adoption, regulatory expectations, and reimbursement approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating varied opportunities and constraints for device developers. In the Americas, strong clinical research infrastructure and a growing emphasis on value-based care foster early clinical validation and private payer engagement, while North American manufacturing and distribution hubs influence sourcing decisions and market entry timing. Transitioning to Europe, Middle East & Africa, regulatory harmonization through regional frameworks and an emphasis on clinical evidence drive a methodical adoption curve that rewards devices demonstrating interoperability and long-term outcomes.

By contrast, the Asia-Pacific region presents a heterogeneous environment where rapid digital health adoption in certain markets coexists with varying regulatory maturity and pricing pressures. Local manufacturing capabilities and government-driven initiatives to expand access to digital health services are significant factors in commercialization planning. Across regions, differences in clinician workflows, patient engagement norms, and health system reimbursement mechanisms require tailored go-to-market strategies. Strategic partners and local clinical champions play a crucial role in navigating these regional nuances and accelerating acceptance among providers and patients.

Competitive and collaborative dynamics among hardware manufacturers, sensor suppliers, analytics pioneers, and clinical research partners driving product differentiation

A focused review of key companies reveals a mix of established medical device manufacturers, specialized sensor suppliers, digital health start-ups, and research-focused instrument makers contributing complementary capabilities. Established medical device firms typically leverage deep clinical relationships and regulatory experience to bring implantable and clinical-grade stationary systems to market, while newer entrants and technology companies advance wearable form factors and consumer-friendly interfaces that facilitate home monitoring. Sensor manufacturers provide the foundational hardware-accelerometers, gyroscopes, and EMG sensors-whose quality directly affects signal fidelity and analytic performance, making supplier partnerships strategically important.

Additionally, companies offering data analytics and AI capabilities are critical for translating multi-modal sensor data into clinically actionable metrics. Research institutes and biotech firms engage with device vendors to validate digital biomarkers and incorporate monitoring solutions into trials, thereby influencing product roadmaps and evidence generation. Across the competitive landscape, collaboration between hardware vendors, software developers, clinical research organizations, and health systems is increasingly common, enabling bundled solutions that address clinical validation, data governance, and deployment. Observing these interdependencies helps stakeholders identify potential partners, acquisition targets, and areas for differentiated investment.

Practical strategic priorities and operational measures to enhance resilience, accelerate clinical adoption, and create differentiated value propositions

Industry leaders can take a series of pragmatic steps to strengthen market position, accelerate adoption, and reduce operational risk. First, prioritizing clinical validation and interoperability will mitigate adoption barriers among hospitals, neurology clinics, and research institutions; investing in peer-reviewed studies and integration capabilities with electronic health records enhances credibility and practical utility. Second, establishing resilient supply chains through dual sourcing, strategic inventory buffers, and nearshoring where feasible will reduce exposure to tariff-driven cost fluctuations and component shortages. These actions support continuity in production and guard against sudden cost escalation.

Third, commercial strategies should reflect end-user needs: solutions for home care settings must emphasize ease of use, long battery life, and remote management, whereas hospital-focused offerings should prioritize data accuracy, regulatory compliance, and workflow integration. Fourth, building partnerships with regional distributors, clinical networks, and research institutes can expedite local market entry and evidence generation. Fifth, technology roadmaps must balance sensor fidelity and analytic sophistication with privacy-by-design and robust cybersecurity practices to satisfy regulators and payers. Finally, considering bundled service models that combine devices with analytics and clinician support can create differentiated value propositions and recurring revenue pathways. Implementing these recommendations will help organizations navigate uncertainty while positioning for sustainable growth.

Transparent, reproducible methodology combining primary interviews, technical assessments, and cross-segmentation analysis to ensure evidence-based insights

The research methodology underpinning this analysis combined qualitative and quantitative evidence gathering to ensure robust, reproducible insights. Primary research included structured interviews with clinicians, procurement officers, device engineers, and clinical trial sponsors to capture first-hand perspectives on clinical utility, usability, and procurement drivers. Supplementing this, technical assessments of device form factors and sensor specifications provided comparative context for fidelity and real-world suitability. Secondary research drew on regulatory guidance, peer-reviewed clinical literature, and publicly available technical documentation to validate clinical and technical claims.

Analytical approaches involved cross-segmentation mapping to identify correlations between product type, end-user requirements, distribution channels, and enabling technologies. Scenario analysis explored supply chain and policy sensitivities, including tariff-related impacts on component sourcing and manufacturing footprints. Throughout, emphasis was placed on triangulating findings across sources to reduce bias and highlight areas where evidence is strong versus where further validation is advisable. The methodology is designed to be transparent and replicable, enabling clients to trace insights back to source inputs and to request deeper dives into specific segments or geographies as needed.

Synthesis of clinical, technical, and commercial imperatives that will determine winners in the evolving landscape of Parkinson's disease monitoring technologies

In conclusion, the Parkinson's disease monitoring device ecosystem is at an inflection point where technological capability, clinical demand for longitudinal objective data, and evolving commercial dynamics converge. Success in this environment requires a clear alignment between device design and end-user workflows, strong clinical evidence of utility, and adaptive commercial strategies that reflect regional regulatory and reimbursement realities. Supply chain resilience and strategic sourcing decisions are increasingly material as policy actions such as tariff adjustments influence component costs and manufacturing decisions.

Looking ahead, organizations that invest in interoperable architectures, prioritize patient-centric design, and cultivate partnerships across clinical and research communities will be best positioned to capture the clinical and commercial advantages of continuous monitoring. By integrating validated analytics and robust data governance practices, developers can build trust with clinicians and payers, supporting broader adoption and enabling more personalized, data-driven care for people living with Parkinson's disease.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Parkinson's Disease Monitoring Device Market, by Product Type

  • 8.1. Non-Wearable Devices
    • 8.1.1. Mobile Apps
    • 8.1.2. Stationary Systems
    • 8.1.3. Tabletop Devices
  • 8.2. Wearable Devices
    • 8.2.1. Footwear Wearables
    • 8.2.2. Implantable Devices
      • 8.2.2.1. Deep Brain Stimulation
      • 8.2.2.2. Neurostimulators
    • 8.2.3. Wrist-Worn Wearables
      • 8.2.3.1. Fitness Bands
      • 8.2.3.2. Smart Watches

9. Parkinson's Disease Monitoring Device Market, by Technology

  • 9.1. Data Analysis Technology
    • 9.1.1. Ai Algorithms
    • 9.1.2. Machine Learning
  • 9.2. Sensor Technology
    • 9.2.1. Accelerometers
    • 9.2.2. Emg Sensors
    • 9.2.3. Gyroscopes

10. Parkinson's Disease Monitoring Device Market, by End User

  • 10.1. Home Care Settings
    • 10.1.1. Assisted Living Facilities
    • 10.1.2. Patient Homes
  • 10.2. Hospitals And Clinics
    • 10.2.1. General Hospitals
    • 10.2.2. Neurology Clinics
  • 10.3. Research Institutes
    • 10.3.1. Biotech Firms
    • 10.3.2. Universities

11. Parkinson's Disease Monitoring Device Market, by Distribution Channel

  • 11.1. Offline Sales
    • 11.1.1. Hospital Sales
    • 11.1.2. Specialty Stores
  • 11.2. Online Sales
    • 11.2.1. Direct Sales
    • 11.2.2. Third Party Retailers

12. Parkinson's Disease Monitoring Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Parkinson's Disease Monitoring Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Parkinson's Disease Monitoring Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Parkinson's Disease Monitoring Device Market

16. China Parkinson's Disease Monitoring Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Biogen Inc.
  • 17.7. BlueSky Medical Group
  • 17.8. Boston Scientific Corporation
  • 17.9. Byteflies NV
  • 17.10. Clario
  • 17.11. Cleveland Medical Devices Inc.
  • 17.12. Gait Up SA
  • 17.13. GE Healthcare, Inc.
  • 17.14. Global Data Sciences Inc.
  • 17.15. Great Lakes NeuroTechnologies, Inc.
  • 17.16. Koneksa Health Corporation
  • 17.17. Koninklijke Philips N.V.
  • 17.18. MC10 Inc.
  • 17.19. Medtronic plc
  • 17.20. mHealth Technologies Srl
  • 17.21. NeuroMetrix, Inc.
  • 17.22. PKG Health Ltd.
  • 17.23. Roche Holding AG
  • 17.24. Siemens Healthineers AG
  • 17.25. uMotif Limited
  • 17.26. Verily Life Sciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TABLETOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FOOTWEAR WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY FITNESS BANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY AI ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ACCELEROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY EMG SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GYROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PATIENT HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY BIOTECH FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITAL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY THIRD PARTY RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY SENSOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY OFFLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY NON-WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY WRIST-WORN WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PARKINSON'S DISEASE MONITORING DEVICE MARKET SIZE, BY DATA ANALYSIS TECHNOLOGY, 2018-2032 (USD MILLION)

TABLE 2